✦Canada Post Xpress1–2 day delivery across CanadaFree on orders over $200
Your cart is empty
ACTH-Derived Research Peptide
Semax Spray is an intranasal research formulation of the Semax peptide studied for its effects on neurotrophic and cognitive-related signaling pathways in laboratory models. Research commonly examines its interaction with brain-derived regulatory mechanisms, receptor activity, and peptide transport dynamics in controlled experimental settings.
Maximum available quantity reached (1)
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH 4–10) with structural modification to enhance stability in experimental systems. It is developed for controlled laboratory research involving neuropeptide signaling pathways.
In scientific literature, Semax is studied in models examining neuroendocrine signaling frameworks, peptide-mediated receptor interaction systems, and downstream regulatory mechanisms under in vitro and preclinical research conditions.
Third-party tested for purity, identity, quantity.
Semax is a modified ACTH fragment evaluated in research focused on neuropeptide signaling and central nervous system pathway interaction. Experimental studies examine its interaction with receptor-mediated signaling frameworks and peptide regulatory systems within controlled laboratory environments.
Research publications have explored its signaling characteristics and pathway-level interaction models under structured experimental conditions.
Semax was developed through investigations into synthetic derivatives of ACTH fragments designed to modify stability and signaling properties. Research expanded into neuropeptide pathway studies and central signaling system frameworks.
Subsequent publications documented its receptor interaction profile and regulatory signaling behavior in laboratory research models.
Laboratory investigations into Semax have focused on neuropeptide signaling models and receptor-mediated pathway interaction systems. Research frameworks evaluate peptide stability, central signaling dynamics, and downstream regulatory mechanisms under controlled in vitro and preclinical conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each unit contains 12mg of Semax in a 10 mL spray presentation delivering 100 mcg per spray. Independent third-party testing verifies purity, identity, and batch specifications.
The product is supplied in a ready-to-use research presentation. No additional laboratory materials are included.
Duration depends entirely on research protocol, storage conditions, and laboratory application.
Related
Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$180.00
Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$10.00
Immune-modulating peptide studied for T-cell signaling and immune system regulatory pathway research
From$70.00
GHRH analog studied for growth hormone regulation and metabolic pathway signaling research
From$95.00
